Toxicity and symptomatic identification of species involved in snakebites in the Indian subcontinent

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 12, Issue 1, 2006, Pages 3-18

  Kumar, V ^a   Maheshwari, R ^a   Verma, H K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Aglyphs; Envenomation; Opistoglyphs; Proteroglyphs; Snakebite; Species specific toxicity

Indexed keywords

ECHIS CARINATUS; VIPERINAE;

EID: 33645864377     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992006000100002     Document Type: Review

References (50)

1. AGRAWAL PN., AGGARWAL AN., GUPTA D., BEHERA D., PRABHAKAR S., JINDAL SK. Management of respiratory failure in severe neuroparalytic snake envenomation. Neurol. India, 2001, 49, 25-8.
2. BAWASKAR HS. Snake venoms and antivenoms: critical supply issues. J. Assoc. Physicians India, 2004, 52, 11-3.
3. BHARAT SERUM, VACCINES LTD. THANE Snake Venom Antiserum I.P., 2001.
4. BLONDHEIM DS., PLICH M., BERMAN M., KHAIR G., TZVIG L., EZRI J, MARMOR AT. Acute myocardial infarction complicating viper bite. Am. J. Cardiol., 1996, 78, 492-3.
5. BOMB BS., ROY S., KUMAWAT DC., BHARJATYA M. Do we need anti-snake venom (ASV) for management of elapid ophitoxaemia? J. Assoc. Physicians India, 1996, 44, 31-3.
6. CHAKRABORTY AK., HALL RH., GHOSE AC. Purification and characterization of a potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell's viper. Mol. Cell. Biochem., 2002, 237, 95-102.
7. CHAND R., NAYAK KC., GUPTA RP., CHADDA S., CHADDA VS. A study of polyvalent antivenom serum therapy in delayed cases of viper snake bite. Ind. Med. Gaz., 1990, 124, 256-60.
8. CHER CDN., ARMUGAM A., ZHU YZ., JEYASEELAN K. Molecular basis of cardiotoxicity upon cobra envenomation. Cell. Mol. Life Sci., 2005, 62, 105-18.
9. CHETTY N., DU A., HODGSON WC., WINKEL K., FRY BG. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms. Toxicon, 2004, 44, 193-200.
10. COSTA LA., FORNARI MC., BERARDI VE., MILES HA., DIEZ RA. In vivo effect of snake phospholipase A2 (crotoxin + cardiotoxin) on serum IL-1 alpha, TNF-alpha and IL-1ra level in humans. Immunol. Lett., 2001, 75, 137-41.
11. CREER S., MALHOTRA A., THORPE RS., STOCKLIN R., FAVREAU PS., HAO CHOU WS. Genetic and ecological correlates of intraspecific variation in pitviper venom composition detected using matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS) and isoelectric focusing. J. Mol. Evol., 2003, 56, 317-29.
12. FOSTER J. Snake envenomations, sea. eMedicine, [serial online], 2005, 1-11 [cited 2005 May 04]. Available from: http://www.emedicine.com/emerg/topic543.htm.
13. FRY BG., WUSTER W., RYAN RAMJAN SF., JACKSON T., MARTELLI P., KINI RM. Analysis of Colubroidea snake venoms by liquid chromatography with mass spectrometry: evolutionary and toxinological implications. Rapid Commun. Mass Spectrom., 2003, 17, 2047-62.
14. GAN GL. Snake venoms. The Singapore Family Physisian, 2002, 28, 40-54.
15. GOMES A., DE P., DASGUPTA S.C. Occurrence of a unique protein toxin from the Indian King Cobra (Ophiophagus hannah) venom. Toxicon, 2001, 39, 363-70.
16. HAZRA A. Poisonous snake bites in India. Community Dev. Med. Unit Ration. Drug. Bull., 2003, 30, 1-12.
17. HUANG SJ., KWAN CY. Inhibition by multivalent cations of contraction induced by Chinese cobra venom cardiotoxin in guinea pig papillary muscle. Life Sci., 1996, 59, 55-60.
18. JENA I., SARANGI A. Snakebite. In: JENA I., SARANGI A. Snakes of medical importance and snake-bite management. New Delhi: Ashish Publishing House, 1993: 99-105.
19. KULARATNE SAM. Common krait (Bungarus caeruleus) bite in Anuradhapura, Sri Lanka: a prospective clinical study, 1996-1998. Postgrad. Med. J., 2002, 78, 276-80.
20. KUMAR SR. Snake bite: an experience. J. Bombay Nat. Hist. Soc., 1991, 88, 460.
21. KUMAR TKS., PANDIAN STK., JAYARAMAN G., PENG HJ., YU C. Understanding the structure, function and folding of cobra toxins. Proc. Natl. Sci. Counc. Repub. China B, 1999, 23, 1-19.
22. LAKHOTIA M., KOTHARI D., CHOUDHARY DR., SHARMA S., JAIN P. A case of saw scale viper snakebite presenting as pleuro-pericardial haemorrhage. J. Indian Acad. Clin. Med., 2002, 3, 392-4.
23. LUMSDEN NG., FRY BG., KINI RM., HODGSON WC. In vitro neuromuscular activity of 'colubrid' venoms: clinical and evolutionary implications. Toxicon, 2004, 43, 819-27.
24. MAGUIRE JH., SPIELMAN A. Ectoparasite infestations and arthropod bites and stings. In: FAUCI AS., BRAUNWALD E., ISSELBACHER KJ., WILSON JD., MARTIN JB., KASPER DL., HAUSER SL., LONGO DL., HARRISON TR. Eds. Harrison's principles of internal medicine. 14.ed. Boston: McGraw-Hill. 1998: 2548-54.
25. MAHESHWARI M., MITTAL SR. Acute myocardial infarction complicating snakebite. J. Assoc. Physicians India, 2004, 52, 63-4.
26. MALHOTRA A., THORPE RS. A phylogeny of the Trimeresurus group of pit vipers: new evidence from a mitochondrial gene tree. Mol. Phylogenet. Evol., 2000, 16, 199-211.
27. MARKLAND FS. Snake venoms and the hemostatic system. Toxicon, 1998, 36, 1749-1800.
28. MEKI AR., EL-DEEN ZM., EL-DEEN HM. Myocardial injury in scorpion envenomed children: significance of assessment of serum troponin I and interleukin-8. Neuroendocrinol. Lett., 2002, 23, 133-40.
29. NAKAMURA M., TANAKA M., ABE S., FUJIWARA H. Sudden pressure elevation can trigger acute muscle cell death of the heart and aorta. Atherosclerosis, 1999, 146, 25-32.
30. NAYAK KC., JAIN AK., SHARDA DP., MISHRA SN. Profile of cardiac complications of snake bite. Indian Heart J., 1990, 42, 185-8.
31. NAYAK KC., SHARDA DP., KOCHAR D., VARMA VK. Epidemiological study of snake bites in Western Rajasthan in the years 1981-1985. Ind. Med. Gaz., 1988, 122, 121-6.
32. NIRTHANAN S., GOPALAKRISHNAKONE P., GWEE MC., KHOO HE., KINI RM. Non-conventional toxins from elapid venoms. Toxicon, 2003, 41, 397-407.
33. NORRIS RL., OSLUND S., AUERBACH PS. Disorders caused by reptile bites and marine animal envenomations. In: FAUCI AS., BRAUNWALD E., ISSELBACHER KJ., WILSON JD., MARTIN JB., KASPER DL., HAUSER SL., LONGO DL., HARRISON TR. Eds. Harrison's principles of internal medicine. 14.ed. Boston: McGraw-Hill, 1998: 2544-8.
34. RADHA KRISHNA MURTHY K., ABBAS ZARE M. Scorpion antivenom reverses metabolic, electrocardiographic and hormonal disturbances caused by the Indian red scorpion Mesobuthus tamulus concanesis, pocock envenomations. J. Venom. Anim. Toxins, 2002, 8, 30-48.
35. SAADEH AM. Case report: acute myocardial infarction complicating a viper bite. Am. J. Trop. Med. Hyg., 2001, 64, 280-2.
36. SAINI RK., SINGH S., SHARMA S., GUPTA VK. Effects of single dose versus serial administration of antivenom serum on coagulation defects in snake bite. Indian J. Pharmacol., 1984, 16, 170-1.
37. SAXENA SC., KUMAR V., MAHESHWARI R., SHARMA A. Development of a computerized QECG acquisition and classification system. In: INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, Chennai, 2001. Proceedings... Chennai: Anna University, 2001. p.115-9.
38. SELVANAYAGAM ZE., GNANAVENDHAN SG., GANESH KA., RAJAGOPAL D., RAO PV. ELISA for the detection of venoms from four medically important snakes of India. Toxicon, 1999, 37, 757-70.
39. SELVANAYAGAM ZE., NEUZIL P., GOPALAKRISHNAKONE P., SRIDHAR U., SINGH M., HO LC. An ISFET-based immunosensor for the detection of beta-bungarotoxin. Biosens. Bioelectron., 2002, 17, 821-6.
40. SENEVIRATNE U., DISSANAYAKE S. Neurological manifestations of snake bite in Sri Lanka. J. Postgrad. Med., 2002, 48, 275-9.
41. SHARMA N., CHAUHAN S., FARUQI S., BHAT P., VARMA S. Snake envenomation in a North Indian hospital. Emerg. Med. J., 2005, 22, 118-20.
42. SIVARAMAN T., KUMAR TK., TU YT., PENG HJ., YU C. Structurally homologous toxins isolated from the Taiwan cobra (Naja naja atra) differ significantly in their structural stability. Arch. Biochem. Biophys., 1999, 363, 107- 15.
43. TSAI IH., WANG YM., CHEN YH., TSAI TS., TU MC. Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri): molecular characterization, geographic variations and evidence of multiple ancestries. Biochem. J., 2004, 377, 215-23.
44. WHITAKER R. Common Indian snakes: a field guide. New Delhi: Macmillan, 1978. 154p.
45. WORLD HEALTH ORGANIZATION. Regional Office for South-East Asia. Management of snake bites in South East Asia. The Clinical Management of Snake Bites in the Southeast Region Asia [serial online], 2003, [cited 2005 May 04]. Available from: http://w3.whosea.org/bct/snake/5.htm.
46. WU CY., CHEN WC., HO CL., CHEN ST., WANG KT. The role of the N-terminal leucine residue in snake venom cardiotoxin II (Naja naja atra). Biochem. Biophys. Res. Commun., 1997, 233, 713-6.
47. WU W. Cobra cardiotoxin and phospholipase A2 as GAG-binding toxins: on the path from structure to cardiotoxicity and inflammation. Trends Cardiovasc. Med., 1998, 8, 270-8.
48. YAMADA D., SEIKIYA F., MORITA T. Prothrombin and factor X activator activities in the venoms of viperidae snakes. Toxicon, 1997, 35, 1581-9.
49. YUGANDHAR B., MURTHY KRK, SATTAR SA. Insulin administration in severe scorpion envenoming. J. Venom. Anim. Toxins, 1999, 5, 200-19.
50. ZHANG Y., TU AT. The effect of snake venom and their components on adrenomedullary cells: catecholamine efflux and cell damage. Neurotoxicology, 2002, 23, 273-9.